13 Feb 2024

Mucosal and systemic immune correlates of viral control after SARS-CoV-2 infection challenge in seronegative adults

Share this:

Co-authored by Alexander Mann – Senior Director of Clinical Science, Andrew Catchpole – Chief Scientific Officer, Mariya Kalinova – Medical Director

Other recent posts

Tripledemic Takedown: How Human Challenge Trials are Ideal to Expedite Multivalent Vaccine Development

Introduction The recent rise of the "tripledemic" – the concurrent spread of the influenza virus, SARS-CoV-2 virus, and respiratory syncytial virus (RSV) – is posing significant risks, especially to older...

Human SARS-CoV-2 challenge uncovers local and systemic response dynamics | Nature

If you’re a potential customer, job seeker, health professional or an investor, find out how hVIVO can help you.